Acquista Criptovalute
Paga con
USD
USD
Buy & Sell
Hot
Supports Visa, Mastercard, SEPA & more
P2P
0 Fees
Flexible trading, zero fees
Gate Card
Use your crypto for payments worldwide
Mercati
Trading
Basic
Advanced
Futures
Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Opzioni
Hot
Trade European-style Vanilla Options
Conto unificato
Massimizza l'efficienza del tuo capitale
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Guadagna
Lancia
CandyDrop
Raccogli le caramelle per guadagnare airdrop
Launchpool
Staking rapido, guadagna potenziali nuovi token
HODLer Airdrop
Fai holding GT e ottieni enormi airdrop gratuitamente
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Investimento
Square
Square
Post, share, and explore crypto trends
Live
moments live
Live crypto market analysis
Chat
Chat with crypto traders
News
What is happening in crypto
flower_head
Altro
Promozioni
AI
Altro
TradFi
WCTC S8
Rewards
BBWI

Prezzo Bath & Body Works Inc

BBWI
$19,26
+$0,27(+1,42%)

*Data last updated: 2026-04-29 11:43 (UTC+8)

As of 2026-04-29 11:43, Bath & Body Works Inc (BBWI) is priced at $19,26, with a total market cap of $3,87B, a P/E ratio of 7,10, and a dividend yield of 4,15%. Today, the stock price fluctuated between $19,03 and $19,49. The current price is 1,20% above the day's low and 1,18% below the day's high, with a trading volume of 3,17M. Over the past 52 weeks, BBWI has traded between $17,09 to $21,66, and the current price is -11,08% away from the 52-week high.

BBWI Key Stats

Yesterday's Close$18,99
Market Cap$3,87B
Volume3,17M
P/E Ratio7,10
Dividend Yield (TTM)4,15%
Dividend Amount$0,20
Diluted EPS (TTM)3,06
Net Income (FY)$649,00M
Revenue (FY)$7,29B
Earnings Date2026-06-04
EPS Estimate0,28
Revenue Estimate$1,36B
Shares Outstanding203,99M
Beta (1Y)1.463
Ex-Dividend Date2026-02-20
Dividend Payment Date2026-03-06

About BBWI

Bath & Body Works, Inc. operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. The company sells its products under the Bath & Body Works, White Barn, and other brand names through specialty retail stores and websites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements. As of January 29, 2022, it operated 1,755 company-operated retail stores and 338 international partner-operated stores. The company was formerly known as L Brands, Inc. and changed its name to Bath & Body Works, Inc. in August 2021. Bath & Body Works, Inc. was founded in 1963 and is headquartered in Columbus, Ohio.
SectorConsumer Cyclical
IndustrySpecialty Retail
CEODaniel Heaf
HeadquartersColumbus,OH,US
Official Websitehttps://www.bbwinc.com
Employees (FY)60,70K
Average Revenue (1Y)$120,11K
Net Income per Employee$10,69K

Bath & Body Works Inc (BBWI) FAQ

What's the stock price of Bath & Body Works Inc (BBWI) today?

x
Bath & Body Works Inc (BBWI) is currently trading at $19,26, with a 24h change of +1,42%. The 52-week trading range is $17,09–$21,66.

What are the 52-week high and low prices for Bath & Body Works Inc (BBWI)?

x

What is the price-to-earnings (P/E) ratio of Bath & Body Works Inc (BBWI)? What does it indicate?

x

What is the market cap of Bath & Body Works Inc (BBWI)?

x

What is the most recent quarterly earnings per share (EPS) for Bath & Body Works Inc (BBWI)?

x

Should you buy or sell Bath & Body Works Inc (BBWI) now?

x

What factors can affect the stock price of Bath & Body Works Inc (BBWI)?

x

How to buy Bath & Body Works Inc (BBWI) stock?

x

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.

Other Trading Markets

BBWI
CFD
Fai trading

Hot Posts su Bath & Body Works Inc (BBWI)

MrRightClick

MrRightClick

2025-12-26 02:35
Bath & Body Works (BBWI) shares experienced a significant selloff following the release of third-quarter fiscal 2025 earnings that disappointed on both revenue and profitability fronts. The company's Q3 results fell short of analyst expectations and declined compared to the prior year, pressured by challenging consumer spending patterns and elevated tariff-related headwinds. Management responded by revising its full-year 2025 guidance downward, triggering the substantial stock decline. Currently rated a Zacks Rank #3 (Hold), BBWI has shed approximately 52% of its value over the past three months, significantly underperforming the broader retail sector's 10.8% decline. However, the company has introduced an ambitious transformation roadmap aimed at revitalizing operations across all business segments. Built on the "Consumer First Formula," this strategic initiative emphasizes four critical pillars: pioneering disruptive and innovative product offerings, rekindling brand momentum, reinforcing competitive marketplace positioning, and accelerating operational efficiency and speed to market. These efforts specifically target attracting younger consumer demographics while positioning BBWI for sustainable long-term growth. The body transformation quotes from leadership suggest an organization committed to reshaping its identity and customer value proposition during turbulent market conditions. ## Q3 Financial Performance: Disappointing Metrics Across the Board BBWI reported adjusted earnings of $0.35 per share for the third quarter, missing the Zacks Consensus Estimate of $0.40 and declining from $0.49 achieved in the prior-year period. Net sales contracted 1% year-over-year to $1.594 billion, falling short of the consensus projection of $1.627 billion. Segmented sales performance revealed mixed results. United States and Canada store net sales edged up just 0.2% year-over-year to $1.22 billion but underperformed the consensus estimate of $1.26 billion. Direct channel sales in the U.S. and Canada experienced a steeper decline, dropping 7% to $299 million against an expected $309 million. International net sales demonstrated relative strength, rising 6.1% to $73 million and meeting consensus expectations. Digital channel performance remains an area requiring focused improvement efforts. The company maintains nearly 40 million active loyalty program members and has launched strategic brand collaborations, including Disney Villains-themed collections, to enhance customer engagement and strengthen brand storytelling. ## Profitability Under Pressure: Margin Compression Analysis Gross profit experienced a notable 6.4% year-over-year decline to $658 million. The gross margin contracted 220 basis points to 41.3% during the quarter, driven by a 260-basis-point deterioration in merchandise margins. Tariff impacts accounted for approximately $35 million or roughly 200 basis points of margin pressure. BBWI elevated promotional intensity to clear seasonal inventory, concluding the quarter with a balanced inventory position. Operating expenses presented a different picture, with general, administrative, and store operating costs increasing 3.1% year-over-year to $497 million. As a percentage of sales, this metric delevered 120 basis points to 31.2%. Consequently, operating income contracted 26.1% to $161 million, compressing the operating margin by 340 basis points to 10.1%. Net income declined 27.4% to $77 million from $106 million in the year-ago quarter. ## Retail Footprint Update and International Expansion BBWI concluded the quarter operating 1,934 North American stores, comprising 1,821 locations in the United States and 113 in Canada. During Q3, the company opened 40 new stores concentrated in off-mall locations while permanently closing 10 mall-based stores. The portfolio mix has evolved favorably, with 59% of the fleet now positioned in off-mall channels. Internationally, partner-operated stores increased by a net 7 locations, ending the quarter at 544 stores. Management reaffirmed that international expansion targets for fiscal 2025 remain achievable, with plans for at least 30 net new store openings. ## Balance Sheet and Capital Allocation Position BBWI maintained $236 million in cash and equivalents at quarter-end, against $3.89 billion in long-term debt and $897 million in long-term operating lease liabilities. Total inventory increased 6.2% compared to the prior-year quarter. Operating cash generation reached $225 million during Q3. The company distributed $41 million in dividends and repurchased 3 million shares at an average price of $29.25 per share, totaling $87 million. Year-to-date shareholder returns encompassed $126 million in dividends and $343 million in share repurchases covering 11.5 million shares. ## Fourth Quarter Guidance: Conservative Outlook Reflects Market Headwinds Management projects fourth-quarter net sales will decline at a high-single-digit percentage versus the $2.788 billion recorded in Q4 fiscal 2024. Fourth-quarter earnings are expected to reach at least $1.70 per share, substantially below the $2.09 achieved in the prior-year quarter. This guidance reflects ongoing negative consumer sentiment and anticipated tariff impacts. The company anticipates a competitive and challenging holiday season beginning in late Q3, with persistent macro pressures tempering consumer purchasing. Management assumes current trends persist through the period while acknowledging modest headwinds from modifications to online purchase policies. Systemwide international retail sales are projected to appreciate at high-single-digit rates, while reported net sales growth is expected in the mid-single-digit range. The company forecasts Q4 gross margin of 44.5%, with tariffs expected to reduce margins by approximately 100 basis points despite mitigation efforts. SG&A expenses are projected at 24% of sales, reflecting weak sales trends partially offset by disciplined cost management. Interest expenses and other costs are estimated at $60 million, with an anticipated 25% tax rate. ## Fiscal 2025 Full-Year Guidance Revision BBWI significantly revised its full-year 2025 outlook. Net sales are now expected to decline at a low-single-digit rate compared to the $7.307 billion achieved in fiscal 2024, representing a substantial downward adjustment from the previous 1.5-2.7% growth projection. Full-year gross margin is now anticipated at approximately 43.3%, with tariffs creating a 100-basis-point headwind offset by mitigation strategies. The adjusted SG&A rate is forecast at 28.3% of sales. Full-year earnings per share are now expected to reach at least $2.83 versus $3.61 in fiscal 2024, while adjusted EPS is projected at a minimum of $2.87 compared to $3.29 in the prior year. These figures incorporate all identified tariff impacts and assume $400 million in planned share repurchases. Free cash flow is projected at approximately $650 million for 2025, compared to the earlier $750-850 million expectation, supported by working capital optimization through "fuel for growth" initiatives. Capital expenditures are budgeted at $240 million, down from the previous $250-270 million guidance range, with primary allocation toward real estate and technology infrastructure. ## Comparative Retail Sector Performance Within the retail sector, Genesco Inc. (GCO) presents an alternative investment thesis, currently rated Zacks Rank #2 (Buy) with a trailing four-quarter average earnings surprise of 28.1%. Consensus estimates project current fiscal-year EPS growth of 71.3% and sales expansion of 3.7%. Five Below (FIVE), a specialty value retailer rated Zacks Rank #2, delivered an average earnings surprise of 50.5% over the past four quarters, with consensus sales growth projections of 16.2% for the current fiscal year. Ulta Beauty (ULTA), currently rated Zacks Rank #2, posted a trailing four-quarter earnings surprise averaging 16.3%, with consensus projections indicating current fiscal-year sales growth of 6.8%.
0
0
0
0
GasFeeTears

GasFeeTears

2025-12-26 02:32
## A Bold Bet on an Overlooked Chemical Giant The market's pessimism toward The Chemours Company (NYSE:CC) has created an opportunity that institutional investors are beginning to notice. Cooper Creek Partners Management, the New York-based investment firm, recently acquired nearly 4 million shares of the chemicals manufacturer during the third quarter, allocating approximately $63.1 million to build this new position. The timing of such a substantial investment—when most market participants remain bearish—raises an important question: has the broader market overlooked Chemours' turnaround potential? ## Understanding the Fund's Strategic Move According to SEC filings disclosed on November 14, Cooper Creek's third-quarter holdings reveal a carefully curated portfolio of 88 U.S. equity positions totaling $3.3 billion. The Chemours stake, representing 1.9% of the fund's reportable assets, ranks as a meaningful allocation. This concentration level suggests the fund sees more than just a speculative opportunity—it reflects conviction in the company's fundamental value. To contextualize this investment, the fund's top holdings include: - OI (NYSE:OI): $130.5 million (4.9% of AUM) - NWL (NASDAQ:NWL): $130.2 million (4.9% of AUM) - CXW (NYSE:CXW): $129.7 million (4.9% of AUM) - BBWI (NYSE:BBWI): $129 million (4.8% of AUM) - AAP (NYSE:AAP): $107 million (4% of AUM) ## The Disconnect Between Price and Potential Chemours shares currently trade at $12.79, presenting a stark contrast to historical valuations. Over the past twelve months, the stock has declined 41%, vastly underperforming the S&P 500's 14% gain. More striking is the long-term picture: shares remain approximately 80% below their 2017 peak, suggesting that decades of industrial value have been erased from investor perception. Yet beneath the depressed valuation lies operational improvement. The company's latest earnings report tells a different story than the market price suggests: - **Third-quarter revenue:** $1.5 billion (essentially flat year-over-year) - **Net income:** $60 million (compared to a $32 million loss in the prior-year quarter) - **TTM revenue:** $5.8 billion - **Dividend yield:** 2.7% The stabilization in profitability despite soft industrial demand reveals a company working through operational challenges rather than facing structural decline. ## Which Business Segments Are Driving Recovery? Chemours manufactures critical materials across multiple sectors: titanium dioxide pigments (Ti-Pure brand), refrigerants (Opteon), advanced performance materials, and industrial chemicals. In the recent quarter, strength in Opteon refrigerants offset weakness in titanium dioxide and advanced materials segments. CEO Denise Dignam noted that "consolidated results exceeded expectations for the quarter," signaling that management's strategic execution remains on track. For investors seeking exposure to industrial chemicals and specialty materials, this operational momentum matters. ## The Investment Thesis: Why Contrarian Bets Sometimes Work When established institutional funds build significant new positions in beaten-down securities, it often signals that they've identified value the consensus has overlooked. In Chemours' case, the formula appears compelling: 1. **Depressed valuation** following years of market skepticism 2. **Improving operations** as the company stabilizes after disruptions 3. **Meaningful cash generation** despite cyclical end-market pressures 4. **Institutional conviction** demonstrated through a material portfolio allocation However, prospective investors should acknowledge the risks: the company carries meaningful leverage, and its end markets remain cyclical. Patience will be required as the turnaround unfolds. The fact that sophisticated capital has bought into Chemours at these levels suggests that the gap between current market pricing and intrinsic value may be worth monitoring—even for those who remain skeptical of the chemicals sector's near-term prospects.
SPOT0,00%
STAKE0,00%
0
0
0
0
DeFiGrayling

DeFiGrayling

2025-12-23 12:07
## The Broader Picture: AI Optimism Fades Thursday's trading session told an interesting story about investor psychology. While Nvidia's better-than-expected quarterly earnings initially sparked enthusiasm across the market, the rally fizzled as quickly as it arrived. This reversal suggests a deeper concern: how sustainable is the current AI-driven bull run? The numbers tell the tale. The Nasdaq Composite dropped 2.15% (-486 points), outpacing losses in the S&P 500 (-1.56%, -103 points) and Dow Jones (-0.84%, -387 points). When growth-heavy indices fall harder than the broader market, it signals profit-taking in exactly the sectors that had climbed highest. ## Winners Defying the Trend Not every stock followed the market downward. Two standout performers captured investor attention for very different reasons. **PACS Group's Remarkable 56% Surge** PACS Group (NYSE: PACS) dominated today's biggest stock gainers list with a staggering 56% jump. The catalyst? Resolution of a long-standing uncertainty. After weeks of investigation, the skilled care facility operator announced that its audit committee had completed its review of past financials, clearing the path for the company to regain SEC compliance. What made this particularly impactful was the underlying business performance. Third-quarter revenues climbed 31% year-over-year to $1.34 billion, with net income reaching $52.3 million—more than tripling its year-ago figure. Investors who had been sidelined by regulatory concerns finally had the green light to re-enter the position. **Exact Sciences Surges on Acquisition News** Exact Sciences (NASDAQ: EXAS) posted a 17% gain after healthcare conglomerate Abbott Labs (NYSE: ABT) announced plans to acquire the cancer screening specialist for $105 per share—a 22% premium to Wednesday's close. For Exact Sciences shareholders, the deal represents a return to valuations unseen since 2021. The synergy potential is clear: Abbott gains the popular Cologuard product line while expanding its cancer diagnostics portfolio. ## Today's Biggest Stock Losers Paint a Different Picture The declines were equally dramatic for companies facing headwinds, offering a cautionary counterpoint to the gains. **Bath & Body Works Disappoints on Multiple Fronts** Bath & Body Works (NYSE: BBWI) plummeted 25% following its third-quarter earnings release. The retail company reported quarterly sales down 1% year-over-year to $1.59 billion, but earnings compression was the real concern—falling to $0.37 per share from $0.49 a year earlier. Looking ahead offers little comfort. Management now anticipates full-year 2025 net sales will decline and earnings will drop substantially versus 2024. The holiday quarter outlook appears particularly weak, with guidance pointing to high-single-digit percentage sales declines and earnings potentially 20% below last year's fourth quarter. In an environment of tariff uncertainty and consumer caution, Bath & Body Works faces a challenging path forward. **SanDisk's AI-Driven Rally Reverses** SanDisk (NASDAQ: SNDK) fell 20% despite receiving what would normally be positive news—Bank of America Securities lifted its price target by $30 to $300 per share. The problem? SanDisk had become almost synonymous with the AI boom, rocketing from $50 in early September to nearly $300 by mid-November. With investors reassessing their exposure to AI-adjacent plays, SanDisk's pullback reflects a broader cooling toward data storage and semiconductor companies that benefited most from AI enthusiasm. The stock had simply run too far, too fast. ## What This Reveals About Market Dynamics Thursday's action illustrates a market in transition. The initial wave of AI optimism has given way to questions about valuation, sustainability, and which companies will actually profit from the technology's adoption. Meanwhile, companies resolving operational uncertainties—like PACS—or offering M&A optionality—like Exact Sciences—found buyers willing to step in. Today's biggest stock losers serve as a reminder that momentum alone doesn't sustain rallies. Bath & Body Works and SanDisk both face structural or valuation challenges that overshadow near-term catalysts.
0
0
0
0